• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Ann Marie Hernandez, MD, MPH

Latest:

Digital Health Implementation Among Older Adults: Health Technology Navigators’ Perspectives

Health technology navigators share perspectives on barriers to and facilitators of digital health access for older, linguistically diverse patients in a Los Angeles safety-net system.


Rebecca Trotzky-Sirr, MD

Latest:

Choosing Wisely Interventions to Reduce Antibiotic Overuse in the Safety Net

This study evaluates the impact of Choosing Wisely–based interventions on antibiotic prescribing for viral respiratory tract infections in a real-world safety-net setting.


Carrie Jardine

Latest:

Optimizing the Management of TRD

Drs Steven Levine, Patricia Ares-Romero, Samuel Nordberg, Martin Rosenzweig, and Carrie Jardine share insight on the future treatment landscape for TRD.


Lena Chaihorsky, BS

Latest:

Medical Policy Determinations for Pharmacogenetic Tests Among US Health Plans

This analysis demonstrated significant variability in medical policy determinations and evidence cited for clinically relevant pharmacogenetic tests among major US health insurers and laboratory benefit managers.



Eugene B. Cone, MD

Latest:

Are Work Relative Value Units Correlated With Operative Duration of Common Surgical Procedures?

Work relative value units (wRVUs) correlate with operative duration of common surgical procedures. Reimbursement for physicians depending on wRVUs is fair for commonly performed surgeries.


Craig A. Portell, MD | Image Credit: © UVA Health
Craig A. Portell, MD

Latest:

Future Research Priorities for Non-Hodgkin Lymphomas: Craig A. Portell, MD

Future research into non-Hodgkin lymphoma treatments needs to explore long-term outcomes and a better understanding of the biologic rationale for various treatments, explained ECHELON-3 principal investigator Craig A. Portell, MD, of UVA Health.


Jason H. Wasfy, MD

Latest:

The Essential Role of Population Health During and Beyond COVID-19

The authors detail how population health management enables health systems to promote public health, strengthen health system resiliency, and support financial recovery during and beyond coronavirus disease 2019 (COVID-19).


E. Camille Vaughan, MD, MS

Latest:

Impact of Electronic Information Exchange on Repeat Imaging During 30-Day Readmissions Among Medicare Beneficiaries

This analysis of Medicare data examines the relationships between fragmented readmission, health information exchange, and repeat imaging in older adults with and without Alzheimer disease.


Julia Bonavitacola
Julia Bonavitacola

Latest:

Mitigating Cardiometabolic Risk Through Therapies, Weight Management

Experts in cardiometabolic conditions gathered in Aurora, Colorado, on August 19, 2025, to discuss the methods available to prevent cardiovascular events.


Beth Creekmur, MA

Latest:

Development and Validation of the COVID-19 Hospitalized Patient Deterioration Index

The authors developed and validated an accurate, well-calibrated, easy-to-implement COVID-19 hospitalized patient deterioration index to identify patients at high or low risk of clinical deterioration.


Lisa Balentine, BASc

Latest:

Tacking Upwind: Reducing Spending Among High-risk Commercially Insured Patients

Although commercial accountable care organization populations are healthy on average, some individuals might benefit from programs for high-risk patients to mitigate high levels of health care utilization.


Alexandra G. Hames, PhD

Latest:

Racial/Ethnic Disparities in Cost-Related Barriers to Care Among Near-Poor Beneficiaries in Medicare Advantage vs Traditional Medicare

Among near-poor Black and Hispanic individuals, Medicare Advantage was associated with increased vision care and some, although not uniform, reductions in access disparities vs traditional Medicare.


Daeho Kim, PhD

Latest:

Comparison of Mortality Between Medicare Advantage and Traditional Medicare Beneficiaries With Kidney Failure

The risk-adjusted 1-year mortality rate was not different between Medicare Advantage and traditional Medicare beneficiaries with kidney failure who initiated dialysis.


Brian P. O’Rourke, MA

Latest:

Integrating Primary Care and Public Health for Advance Care Planning

This article proposes a new model, Public-Primary ACP, that leverages coordination between primary care and public health workforces to improve delivery of advance care planning.


Taylor Turner, MPH

Latest:

Addressing STIs Through Managed Care: Opportunities in Medicaid and Beyond

Medicaid and other managed care organizations could take several key steps to respond to the sexually transmitted infection (STI) epidemic in the US, including congenital syphilis.


Esther Yi, PharmD

Latest:

Perspectives on Nonmedical Switching and the COVID-19 Pandemic: A Narrative Review

This review describes the impact of nonmedical switching of biologic therapies on US patients and providers, with a focus on switching to in-class alternatives.


Renaldo C. Blocker, PhD

Latest:

Understanding the Complexities of Equity Within the Emergence and Utilization of AI in Academic Medical Centers

This editorial discusses positions for academic medical centers to consider when designing and implementing artificial intelligence (AI) tools.


Qiang Yang, PhD

Latest:

Dosage and Outcomes in a Complex Care Intervention

Associations between intervention dosage and hospital use outcomes were observed among patients enrolled in a care management program serving individuals with complex needs.


Elizabeth Jones, MD, FAAD

Latest:

Strategies for Improving Patient Access to Dermatology Care

Elizabeth Jones, MD, FAAD, highlights the persistent issue of insurance companies favoring expensive, newer medications over equally effective generics in dermatology, emphasizing the time-consuming prior authorization process and advocating for patient partnerships and systemic improvements.


Fayolah Richards, PharmD

Latest:

Insurer Costs of COVID-19 by Disease Severity and Duration

Payer costs for COVID-19 ranged from a mean of $505 for asymptomatic cases to $126,094 for severe cases with post–COVID-19 condition.


Kristine Burnaska, PhD

Latest:

AI in Health Care: Closing the Revenue Cycle Gap

This commentary explores the current state, challenges, and potential of artificial intelligence (AI) in health care revenue cycle management, emphasizing collaboration, data standardization, and targeted implementation to enhance adoption.


Shachar Peles, MD

Latest:

Emerging Multiple Myeloma Data and Future Outlook From ASCO 2025

Panelists discuss how upcoming ASCO presentations will focus on long-term CAR T-cell therapy outcomes showing potential cure plateaus, minimal residual disease (MRD)–guided treatment escalation/de-escalation strategies, tri-specific antibodies, and the economic value of using MRD negativity to guide maintenance therapy discontinuation decisions.


Xiang Huang, MD, PhD

Latest:

How Do Primary Community Hospitals Enact Early Response to COVID-19? The Experience From Chengdu, China

Our hospital is a primary hospital in Chengdu, China. Since February 5, our hospital has been listed as the primary designated medical unit for treating new patients with coronavirus disease 2019 (COVID-19) in Jinniu District. In this letter, we share our COVID-19 experience with readers.


Cori Rattelman, MS

Latest:

Health Systems and Telemedicine Adoption for Diabetes and Hypertension Care

Small practices reduced their use of telemedicine during early stages of the COVID-19 pandemic. Technical support may help expand and maintain telemedicine in small practices.


Richard J. McCarthy, MD

Latest:

Patient Experience After Modifying Visit Delivery During the COVID-19 Pandemic

Coronavirus disease 2019 (COVID-19) was associated with immediate weekly visit trend decreases for overall, primary care, and specialty care with long-term recovery trends; transformation to virtual visits; and increasing long-term trends for meeting patient scheduling and visit needs.


Cui Zhai, PhD

Latest:

Determinants of ICS Therapy Adherence in Patients With Asthma

This study describes determinants affecting disease control and inhaled glucocorticosteroid therapy adherence for patients with asthma in western China.


Kevin A. Peterson, MD, MPH

Latest:

Diabetes Care Quality: Do Large Medical Groups Perform Better?

Large medical groups perform better than medium- or small-sized groups on diabetes quality measures, perhaps because they have more care management processes in place.


Tricia Lee Rolle, PharmD, PhD, MS

Latest:

Physicians in ACOs Report Greater Documentation Burden

An analysis of nationally representative survey data from 2019 and 2021 shows that office-based physicians participating in accountable care organizations (ACOs) reported greater documentation burden across several measures.


Sue Chen, MS

Latest:

Transitional Care Management Visits to Improve Coordination of Care

Inspira Care Connect, LLC, an accountable care organization, incorporated transitional care management services into its postdischarge follow-up process to prevent avoidable utilization of health care services and costs.

© 2025 MJH Life Sciences
AJMC®
All rights reserved.